⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL7618853 | 1.00 | — | — | |
| Ammonia Solution, Strong SCHEMBL2749074 | 1.00 | — | — | |
| Ammonia Solution, Strong SCHEMBL18606030 | 0.91 | — | — | |
| Ammonia Solution, Strong SCHEMBL2168836 | 0.91 | — | — | |
| SCHEMBL22689 | 0.89 | — | — | |
| Water SCHEMBL25354626 | 0.80 | — | — | |
| Water SCHEMBL28489054 | 0.80 | — | — | |
| Phosphine SCHEMBL5852309 | 0.80 | — | — | |
| SCHEMBL29195976 | 0.80 | — | — | |
| Water SCHEMBL3800295 | 0.80 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 55685 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4748859-A2 | CHEMICALLY AND PHOTOCHEMICALLY INITIATED CELL MEMBRANE BLEBBING TO INDUCE CELL VESICLE PRODUCTION, MODIFICATIONS THEREOF, AND USES THEREOF | The Regents of the University of California (US) | 2026-05-27 | — | — | EP | claimed |
| EP-4743490-A1 | HUMANIZED ANTI-CD7 ANTIBODY | Christian-Albrechts-Universität zu Kiel (DE) | 2026-05-20 | — | — | EP | claimed |
| WO-2026099502-A1 | NOVEL DRUG CONJUGATES FOR TESTING CELLULAR DRUG UPTAKE | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts (DE) | 2026-05-15 | — | — | WO | claimed |
| WO-2026101232-A1 | POLYMER COMPOUND FOR CELL SURFACE MODIFICATION FOR IMPROVING DRUG DELIVERY EFFICIENCY | 동국대학교 산학협력단 | 2026-05-15 | — | — | WO | claimed |
| US-20260115305-A1 | LINKERS, CONJUGATES AND APPLICATIONS THEREOF | GENEQUANTUM HEALTHCARE SUZHOU CO LTD (CN) | 2026-04-30 | — | — | US | claimed |
| US-20260108619-A1 | CONJUGATION LINKERS, CELL BINDING MOLECULE-DRUG CONJUGATES CONTAINING THE LINKERS, METHODS OF MAKING AND USES SUCH CONJUGATES WITH THE LINKERS | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2026-04-23 | — | — | US | claimed |
| EP-3515892-B1 | COMPOUNDS AND METHODS FOR IDO AND TDO MODULATION, AND INDICATIONS THEREFOR | PLEXXIKON INC (US) | 2026-04-15 | — | — | EP | claimed |
| US-12594338-B2 | Cisplatin analogue with potent anti-cancer effects and synthesis thereof | KING FAISAL SPECIALIST HOSPITAL & RESEARCH CENTRE (SA) | 2026-04-07 | — | — | US | claimed |
| EP-4717708-A1 | HYDROGEL COMPRISING COLLAGEN CROSSLINKED BY PLATINUM COMPLEX | WASEDA UNIVERSITY (JP) | 2026-04-01 | — | — | EP | claimed |
| US-20260085100-A1 | METHODS OF ANTIGEN PRODUCTION | THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY (US) | 2026-03-26 | — | — | US | claimed |
| EP-0221382-A1 | Method and compositions for the treatment of tumors comprising a calcium channel blocker compound of the dihydropyridine class and a platinum coordination compound | THE BOARD OF GOVERNORS OF WAYNE STATE UNIVERSITY (US) | 1987-05-13 | — | — | EP | claimed |
| US-4590001-A | REACTION WITH CIS-DICHLORODIAMMINEPLATINUM IN THE PRESENCE OF CYSTEINE AND BICARBONATE | MASTOLOGY RESEARCH INSTITUTE, THE | 1986-05-20 | — | — | US | claimed |
| US-4557934-A | ALONG WITH A DIOL PYRROLIDONE OR AN AZACYCLOPENTAN-2-ONE | THE PROCTER & GAMBLE COMPANY (US) | 1985-12-10 | — | — | US | claimed |
| EP-0163316-A1 | Platinum-intercalative complexes for the treatment of cancer | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1985-12-04 | — | — | EP | claimed |
| US-4532122-A | Administering intraperitoneally aqueous solution of cisplatin, subcutaneously physiologic saline, orally disulfiram or parenterally diethyl dithiocarbamate | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) | 1985-07-30 | — | — | US | claimed |
| EP-0026813-B1 | (N-PHOSPHONOACETYL-L-ASPARTATO) (1,2 DIAMINOCYCLOHEXANE) PLATINUM (II) AND THE SODIUM, POTASSIUM OR LITHIUM SALTS THEREOF, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce (US) | 1984-10-03 | — | — | EP | claimed |
| US-4426372-A | SULFIRAM OR DIALKYL DITHIOCARBAMATE | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 1984-01-17 | — | — | US | claimed |
| US-4419340-A | POLYGLYCOLIC OR LACTIC ACID | UNIVERSITY OF DELAWARE (US) | 1983-12-06 | — | — | US | claimed |
| US-4283342-A | REACTION PRODUCT OF A HYDROXYQUINONE AND A CIS-PLATINUM COMPOUND | UNIVERSITY OF DELAWARE (US) | 1981-08-11 | — | — | US | claimed |
| EP-0026813-A2 | (N-phosphonoacetyl-L-aspartato) (1,2 diaminocyclohexane) platinum (II) and the sodium, potassium or lithium salts thereof, their preparation and pharmaceutical compositions containing them | THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce (US) | 1981-04-15 | — | — | EP | claimed |